Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
7.77
+0.09 (1.17%)
Aug 18, 2026, 2:01 PM EDT - Market open
CPIX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.86 | 11.44 | 17.96 | 18.32 | 19.76 | 27.04 |
Cash & Short-Term Investments | 3.86 | 11.44 | 17.96 | 18.32 | 19.76 | 27.04 |
Cash Growth | -75.99% | -36.29% | -1.95% | -7.27% | -26.93% | 9.24% |
Receivables | 13.42 | 16.94 | 11.7 | 9.76 | 13.16 | 6.88 |
Inventory | 0.03 | 6.23 | 4 | 4.61 | 9.86 | 8.43 |
Prepaid Expenses | 0.68 | 2.45 | 2.79 | 3.03 | 3.08 | 3.34 |
Other Current Assets | 15.65 | - | - | - | - | - |
Total Current Assets | 33.64 | 37.06 | 36.45 | 35.71 | 45.87 | 45.69 |
Property, Plant & Equipment | 7.53 | 8.61 | 6.45 | 7.04 | 5.5 | 1.47 |
Long-Term Investments | - | 3.99 | - | - | - | - |
Goodwill | - | 0.91 | 0.91 | 0.91 | 0.91 | 0.88 |
Other Intangible Assets | 0.04 | 14.03 | 17.97 | 22.61 | 30.59 | 23.95 |
Other Long-Term Assets | 21.66 | 12.23 | 13.79 | 15.5 | 10.05 | 12.47 |
Total Assets | 62.88 | 76.82 | 75.58 | 81.78 | 92.93 | 84.46 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 19.55 | 18.57 | 13.91 | 14.04 | 10.82 | 9.64 |
Accrued Expenses | 7.52 | 10.03 | 9.74 | 9.16 | 10.8 | 5.04 |
Short-Term Debt | - | - | 5.1 | - | - | - |
Current Portion of Leases | 0.5 | 0.47 | 0.36 | 0.35 | 0.17 | 0.97 |
Other Current Liabilities | 7.62 | 7.68 | 2.51 | 4.43 | 6.79 | 3.63 |
Total Current Liabilities | 35.19 | 36.74 | 31.62 | 27.98 | 28.58 | 19.28 |
Long-Term Debt | - | 5.24 | 10.18 | 12.78 | 16.2 | 15 |
Long-Term Leases | 4.21 | 4.47 | 4.94 | 5.3 | 4.59 | 0.09 |
Other Long-Term Liabilities | 6.37 | 5.82 | 6.3 | 6.45 | 7.59 | 7.49 |
Total Liabilities | 45.77 | 52.28 | 53.04 | 52.52 | 56.95 | 41.86 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 51.81 | 51.68 | 46.82 | 47.09 | 47.47 | 48.45 |
Retained Earnings | -34.37 | -26.8 | -23.97 | -17.49 | -11.21 | -5.64 |
Total Common Equity | 17.44 | 24.88 | 22.85 | 29.6 | 36.27 | 42.81 |
Minority Interest | -0.33 | -0.34 | -0.31 | -0.34 | -0.29 | -0.21 |
Shareholders' Equity | 17.11 | 24.54 | 22.55 | 29.26 | 35.97 | 42.6 |
Total Liabilities & Equity | 62.88 | 76.82 | 75.58 | 81.78 | 92.93 | 84.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.71 | 10.18 | 20.57 | 18.43 | 20.96 | 16.06 |
Net Cash (Debt) | -0.85 | 1.26 | -2.61 | -0.11 | -1.2 | 10.98 |
Net Cash Growth | - | - | - | - | - | 43.03% |
Net Cash Per Share | -0.06 | 0.09 | -0.19 | -0.01 | -0.08 | 0.74 |
Filing Date Shares Outstanding | 14.98 | 14.96 | 13.97 | 14.18 | 14.4 | 14.84 |
Total Common Shares Outstanding | 14.98 | 14.96 | 13.95 | 14.12 | 14.37 | 14.74 |
Working Capital | -1.55 | 0.32 | 4.83 | 7.73 | 17.29 | 26.41 |
Book Value Per Share | 1.16 | 1.66 | 1.64 | 2.10 | 2.52 | 2.90 |
Tangible Book Value | 17.39 | 9.94 | 3.97 | 6.08 | 4.76 | 17.98 |
Tangible Book Value Per Share | 1.16 | 0.66 | 0.28 | 0.43 | 0.33 | 1.22 |
Machinery | - | 1.93 | 1.84 | 1.81 | 1.58 | 2.81 |
Leasehold Improvements | - | 0.84 | 0.83 | 0.8 | 0.79 | 1.42 |